Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies

Nuclear Medicine Communications

Volumn 28, Issue 6, 2007, Pages 451-456

  Kemp, Paul M ^a   Hoffmann, Sandra A ^a   Tossici Bolt, Livia ^a   Fleming, John S ^b   Holmes, Clive ^c  

^a Departments of Nuclear Medicine and Medical Physics   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c MOORGREEN HOSPITAL   (United Kingdom)

Author keywords

DLB; FP CIT; HMPAO; Lewy body dementia; SPECT

Indexed keywords

FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA 4 IODOPHENYLTROPANE I 123; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BRAIN PERFUSION; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; HUMAN; MAJOR CLINICAL STUDY; OCCIPITAL LOBE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; OCCIPITAL LOBE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34247626340     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328155d143     Document Type: Article

References (31)

1. McKeith IG. Dementia with Lewy bodies: a clinical review. In: Burns A, O'Brien J, Arnes D (editors): Dementia, 3rd edition. London: Hodder Arnold; 2005, pp. 603-614.
2. McKeith IG O'Brien J. Dementia with Lewy bodies. Aust NZ J Psychiat 1999; 33:800-808.
3. McKeith IG, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305:673-678.
4. Ishii K, Imamwa T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy Bodies and Alzheimer's disease. Neurology 1998; 51:125-130.
5. 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med 2002; 29:615-622.
6. Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001; 50:358-365.
7. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56:643-649.
8. Holmes C, Cairns N, Lantos P, Mann A. Validity of clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiat 1999; 174:45-50.
9. Benamer HTS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of I-123 FP-CIT SPECT imaging: The I-123 FP-CIT Study Group. Mov Disord 2000; 15:503-510.
10. Walker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiat 2002; 73:134-140.
11. Costa DC, Walker Z, Walker RW, Fontes FR. Dementia with Lewy bodies versus Alzheimer's disease: Role of dopamine transporter imaging. Mov Disord 2003; 18:S34-S38.
12. Christoff K. SPM99: Protocols, tools, and documentation. Available at: Accessed January 2007.
13. 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia. Nucl Med Commun 2005; 26:1099-1106.
14. Mega MS, Masterman DL, Benson F, Vinters HV, Tomiyasu U, Craig AH, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. Neurology 1996; 47:1403-1409.
15. Luis CA, Barker WW, Gajara K, Harwood D, Petersen R, Kashuba A, et al. Sensitivity and specificity of threee clinical criteria for dementia with Lewy bodies in an autopsy verified sample. Int J Geriatr Psychiatry 1999; 14:526-533.
16. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54:1050-1058.
17. 99mTc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med 2002; 29:1342-1348.
18. Ceravolo R, Volterrani D, Gambaccini G, Rossi C, Logi C, Manca G, et al. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease. Neurol Sci 2003; 24:162-163.
19. 123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006; 33:248-253.
20. Mito Y, Yoshida K, Yabe L, Makino K, Hirotani M, Tashiro K, et al. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin Neurol Neurosurg 2005; 107:396-403.
21. Hanyu H, Schimizu S, Hirao K, Kanetaka H, Sakurai H, Iwamoto T, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT. J Neurol Sci 2006; 250:97-102.
22. Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E. Regional cerebral blood flow differences between dementia with Lewy bodies and AD. Neurology 1999; 53:413-416.
23. Shimizu S, Hanyu H, Kanetaka H, Iwamoto T, Koizumi K, Abe K. Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord 2005; 20:25-30.
24. Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 2000; 162:247-256.
25. Barber R, Gholkar A, Sheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999; 52:1153-1158.
26. Pasquier F, Hamon M, Lebert F, Jacob B, Pruvo JP Petit H. Medial temporal lobe atrophy in memory disorders. J Neurol 1997; 244:175-181.
27. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003; 20:1309-1319.
28. Defebvre LJP, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999; 40:956-962.
29. Imamura T, Ishii K, Sasaki M, Kitagaki H, Yamaji S, Hirono N, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci Lett 1997; 235:49-52.
30. O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, et al. Dopamine transporter loss visualised with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004; 61:919-925.
31. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Dementia with Lewy bodies: Diagnosis and management. Third Report of the DLB Consortium. Neurology 2005; 65:1863-1872.